Aardvark Therapeutics, Inc. Common Stock Defensive Interval Ratio
Aardvark Therapeutics, Inc. Common Stock defensive interval ratio. Aardvark Therapeutics, Inc. Common Stock (AARD) has a Defensive Interval Ratio of 2960 days as of September 2025. Defensive assets of $87.06 Million (cash $-, short-term investments $87.06 Million, receivables $-) cover 2960 days of daily cash needs of $29.41K/day. See AARD working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Aardvark Therapeutics, Inc. Common Stock (2022–2024)
Defensive interval ratio of Aardvark Therapeutics, Inc. Common Stock from 2022 to 2024. This chart shows how Aardvark Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the ratio stands at 2960 days, meaning defensive assets of $87.06 Million can fund 2960 days of operations without new revenue. Check AARD asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Aardvark Therapeutics, Inc. Common Stock Defensive Interval Ratio by Year (2022–2024)
Aardvark Therapeutics, Inc. Common Stock defensive interval ratio by year from 2022 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Aardvark Therapeutics, Inc. Common Stock from 2022 to 2024, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see AARD total asset value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 891 days | $12.02 Million | $13.50K/day | $- | $12.02 Million | ▲ +824 days |
| 2023 | 67 days | $254.00K | $3.79K/day | $- | $254.00K | ▼ -268 days |
| 2022 | 335 days | $546.00K | $1.63K/day | $- | $546.00K | — |